ALS Investment Fund
Status
ACTIVE
Global HQ
Amsterdam, Netherlands
Countries of investment
- USA
Investment stages
- Seed
- Series A
- Series B
Industries
- Biotechnology
- Health Tech
- AI
About
ALS Investment Fund backs biotech firms targeting neurodegenerative diseases like ALS, Alzheimer’s, and Parkinson’s. The fund supports platform-based approaches and experienced scientific leadership.
ALS Investment Fund backs biotech firms targeting neurodegenerative diseases like ALS, Alzheimer’s, and Parkinson’s. The fund supports platform-based approaches and experienced scientific leadership.
Investment Thesis
They invest in biotech companies developing drugs in a specialized area of disease: neurodegeneration, with a particular focus in ALS.
Manager's Experience
Focused on early-stage investments in technology-driven sectors, with a strong emphasis on fintech and healthtech. Backed 50+ startups across North America and Europe, showcasing a commitment to identifying high-potential opportunities. Known for a hands-on investment style that fosters operational excellence and rapid market entry. Recognized for achieving multiple successful exits, demonstrating a keen eye for growth and value creation in niche markets.
Team
Craig Boyce
Felix Von Coerper